Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • U.S. Psychedelic Policy Reform
    • Worldwide Psychedelic Laws
    • Oregon Psilocybin Services Tracker
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • U.S. Psychedelic Policy Reform
    • Worldwide Psychedelic Laws
    • Oregon Psilocybin Services Tracker
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Filament Health Files 20th Patent Application Including Three International PCT Applications

Filament Health Files 20th Patent Application Including Three International PCT Applications

  • Post published:September 1, 2021
  • Post category:Press Release
Read more about the article Filament Health Successfully Completes Industry-first Export of Natural GMP Psychedelics to the United States

Filament Health Successfully Completes Industry-first Export of Natural GMP Psychedelics to the United States

  • Post published:August 26, 2021
  • Post category:Press Release
Read more about the article Filament Health Announces Q2 2021 Financial Results

Filament Health Announces Q2 2021 Financial Results

  • Post published:August 16, 2021
  • Post category:Press Release
Read more about the article Filament Health Is the First Public Company to Be Issued a Patent for Extraction of Natural Psilocybin

Filament Health Is the First Public Company to Be Issued a Patent for Extraction of Natural Psilocybin

  • Post published:August 3, 2021
  • Post category:Press Release
Read more about the article Regulatory Approvals Place Filament Health at the Forefront of Natural Psychedelic Research and Manufacturing

Regulatory Approvals Place Filament Health at the Forefront of Natural Psychedelic Research and Manufacturing

  • Post published:July 29, 2021
  • Post category:Press Release
Read more about the article Filament Health to Host Virtual Investor Event

Filament Health to Host Virtual Investor Event

  • Post published:July 20, 2021
  • Post category:Press Release
Read more about the article Exclusively-Natural Psychedelic Pharma Company, Filament Health, Lists on the NEO Exchange

Exclusively-Natural Psychedelic Pharma Company, Filament Health, Lists on the NEO Exchange

  • Post published:June 24, 2021
  • Post category:Press Release
Read more about the article Interview: Dr. Josh Woolley (TrPR) and Ben Lightburn (Filament Health)

Interview: Dr. Josh Woolley (TrPR) and Ben Lightburn (Filament Health)

  • Post published:June 22, 2021
  • Post category:Interview
Read more about the article Filament Health Corp. Announces Approval for Listing on the Neo Exchange

Filament Health Corp. Announces Approval for Listing on the Neo Exchange

  • Post published:June 22, 2021
  • Post category:Press Release
Read more about the article Filament Announces Shareholder Approval of Amalgamation and Closing of Private Placement Financing

Filament Announces Shareholder Approval of Amalgamation and Closing of Private Placement Financing

  • Post published:June 21, 2021
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More